OTCM
ZTFMF
Market cap320mUSD
Oct 20, Last price
6.55USD
Name
Zotefoams PLC
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Zotefoams plc, established in 1921 and headquartered in Croydon, UK, is a global leader in the manufacturing, distribution, and sale of polyolefin block foams. The company serves markets across the United Kingdom, Continental Europe, North America, and other international regions, structured around its Polyolefin Foams, High-Performance Products, and MuCell Extrusion LLC segments. Its product portfolio encompasses the AZOTE range of polyolefin foams, known by brands such as Plastazote, Evazote, and Supazote. Furthermore, Zotefoams develops high-performance foams under the ZOTEK brand, which are formulated from advanced materials including fluoropolymers, engineering polymers, and specialized elastomers. The company also supplies T-FIT, a sophisticated clean insulation solution vital for pharmaceutical, biotech, and semiconductor cleanroom applications. Beyond its product lines, Zotefoams possesses and licenses the patented MuCell microcellular foam technology, complementing this with the sale of related machinery. These diverse offerings are utilized across a broad spectrum of industries, notably automotive, aerospace, product protection, industrial parts, marine, building and construction, military, and sports and leisure.
Key people
Ronan Cox
Group Chief Executive Officer, Executive Director · since 2024
Clare Farmer
Chief People Officer · since 2024
Simon Jones
Managing Director, EMEA · since 2024
Dan Lumpkin
Managing Director, North America · since 2024
Hugh Morgan
Managing Director - Footwear · since 2024
Nick Wright
Group Chief Financial Officer - Designate, Executive Director · since 2025
Simon Comer
Group Strategy & Delivery Director · since 2024
Karl Hewson
Group Innovation Director · since 2024
Oliver Ridd
Group Commercial Director · since 2024
Benito Sala
Group Supply Chain & Operations Director · since 2024
Lydia Harratt
Company Secretary
Non-Executive Independent Chair of the Board · since 2023
Jonathan Carling
Non-Executive Independent Director · since 2018
Non-Executive Independent Director · since 2025
Senior Independent Non-Executive Director · since 2018
Malcolm Swift
Non-Executive Independent Director · since 2023
Catherine Wall
Non-Executive Independent Director · since 2020
Headquarters & legal address
602-3 Salisbury House 29
London, LND EC2M 5SQ
GB
London, LND EC2M 5SQ
GB
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||